HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Congenital erythropoietic porphyria: mutation update and correlations between genotype and phenotype.

Abstract
High quality genotype/phenotype analysis is a difficult issue in rare genetic diseases such as congenital erythropoietic porphyria (CEP) or Günther's disease, a heme biosynthesis defect due to uroporphyrinogen III synthase deficiency. The historical background and the main phenotypic features of the disease are depicted together with an update of published mutants and genotype/phenotype correlations. General rules concerning the prediction of disease severity are drawn as a guide for patient management and therapeutic choices. The phenotypic heterogeneity of the disease is presented in relation with a likely influence of modifying factors, either genetic or acquired.
AuthorsC Ged, F Moreau-Gaudry, E Richard, E Robert-Richard, H de Verneuil
JournalCellular and molecular biology (Noisy-le-Grand, France) (Cell Mol Biol (Noisy-le-grand)) Vol. 55 Issue 1 Pg. 53-60 (Feb 16 2009) ISSN: 1165-158X [Electronic] France
PMID19268002 (Publication Type: Journal Article, Review)
Chemical References
  • Uroporphyrinogen III Synthetase
Topics
  • Genotype
  • Humans
  • Mutation (genetics, physiology)
  • Phenotype
  • Porphyria, Erythropoietic (enzymology, genetics)
  • Uroporphyrinogen III Synthetase (genetics, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: